First Tracks Biotherapeutics, Inc. (TRAX)
45.80
+2.32
(+5.35%)
USD |
NASDAQ |
Oct 27, 14:30
First Tracks Biotherapeutics Total Liabilities (Quarterly) : 14.34M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.34M |
| Date | Value |
|---|---|
| March 31, 2026 | 33.11M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AnaptysBio, Inc. | 335.42M |
| Mirum Pharmaceuticals, Inc. | 1.055B |
| Biogen, Inc. | 13.24B |
| Immunovant, Inc. | 117.10M |
| Forte Biosciences, Inc. | 21.95M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 183.14M |
| Shareholders Equity (Quarterly) | 168.80M |
| Debt to Equity Ratio | 0.0257 |
| Current Ratio | 14.28 |
| Net Debt Paydown Yield | -0.15% |